Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients (GetUp Trial)

NCT02500329 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02500329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02500329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients (GetUp Trial)
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2014
Completion date
Not reported
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acarbose, endothelial function, gemigliptin, type 2 diabetes